5/9/2025

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Source: Yahoo

5/8/2025

Pacific Biosciences (PACB) delivered earnings and revenue surprises of 21.05% and 6.15%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/8/2025

STERIS (NYSE:STE) recently affirmed its commitment to shareholder value with the announcement of a quarterly interim dividend of $0.57 per share, set for payment in late June 2025. Over the last month, the company’s share price rose 6%, potentially bolstered by this dividend affirmation, underscoring its financial stability. This moves comes amidst wider market optimism spurred by news of a trade deal between the U.S. and U.K. The general market rise did see major indices like the Dow and S&P...

Source: Yahoo

5/7/2025

DUBLIN, IRELAND, May 07, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.57 per share. The dividend is payable on June 26, 2025, to shareholders of record at the close of business on June 10, 2025. Additional information about the U.S. tax treatment of dividends, including required Forms 8937, is available at www.steris-ir.com. STERIS is a leading global provider of products and servic

Source: Yahoo

5/7/2025

Steris PLC stock outperforms competitors on strong trading day

Source: MarketWatch

5/7/2025

Top 10 undervalued dividend growth stocks with projected growth rates of 10%+. Click here for more dividend quick picks and lists.

Source: SeekingAlpha

5/7/2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Source: Yahoo

5/6/2025

STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.

Source: Yahoo

5/6/2025

The surprise emergence in January of DeepSeek stoked fears about the returns to be expected from the massive investment being made in the AI ecosystem. Read more here.

Source: SeekingAlpha

5/2/2025

Steris PLC stock rises Friday, still underperforms market

Source: MarketWatch

5/1/2025

Hologic (HOLX) delivered earnings and revenue surprises of 0.98% and 0.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/1/2025

Steris PLC stock outperforms competitors despite losses on the day

Source: MarketWatch

4/26/2025

We recently published a list of the 10 Overlooked Dividend Stocks to Buy Now. In this article, we are going to take a look at where STERIS plc (NYSE:STE) stands against other overlooked dividend stocks. In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, […]

Source: Yahoo

4/24/2025

Steris PLC stock rises Thursday, still underperforms market

Source: MarketWatch

4/22/2025

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2025 fourth quarter and full year financial results at 9:00 a.m. ET on May 15, 2025. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing fi

Source: Yahoo

4/22/2025

Steris PLC stock rises Tuesday, still underperforms market

Source: MarketWatch

4/21/2025

Steris PLC stock underperforms Monday when compared to competitors

Source: MarketWatch

4/16/2025

STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.

Source: Yahoo

4/16/2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 14.8%. This performance was worse than the S&P 500’s 8.5% decline.

Source: Yahoo

4/14/2025

Steris PLC stock underperforms Monday when compared to competitors despite daily gains

Source: MarketWatch